Pricing policies hit industry in Portugal
This article was originally published in Scrip
Executive Summary
Pharmaceutical companies in Portugal saw their net sales fall by an average of 12% between 2006 and 2008, largely because of pricing regulations there, says a study conducted by Hay Group.